Revian

Revian develops at-home light therapy devices designed to address hair loss and stimulate natural hair regrowth using low-level light therapy (LLLT). The company's core product, the Revian Red system, uses a patented combination of 620nm and 660nm wavelengths delivered through an LED-based wireless cap paired with a mobile app. Treatment requires just 10 minutes daily, and the company reports that their therapy is clinically proven to grow more hair in less time compared to topical and pharmaceutical alternatives.

Revian's approach centers on harnessing light to address the biological mechanisms underlying hair loss. The company's research indicates their dual-wavelength technology can reduce DHT (dihydrotestosterone), a key factor in pattern baldness, while stimulating the scalp's natural regenerative processes. The system integrates treatment tracking, photo journaling, and compliance monitoring through a dedicated app, allowing users to manage their protocol from home without requiring ongoing practitioner visits.

The company positions itself as an evidence-based alternative to chemical treatments and prescription medications. Revian has completed over 5 million treatments, maintains partnerships with 2,000+ US medical providers, and holds 61 light science patents. Their money-back guarantee requires consistent use over 145 days out of 180, reflecting confidence in measurable outcomes.